Join to View Full Profile
151 C. de San FranciscoPiso PrimeroSan Juan, PR 00901
Dr. Hermann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Board-certified radiologist with expertise in diagnostic imaging and clinical workflows.
Founder of RightReadMD, a physician-led teleradiology group delivering final reads with speed, accuracy, and direct clinician access — no prelims, no ticket systems.
We work with imaging centers, urgent care groups, and outpatient providers to deliver fast turnaround and reliable U.S.-licensed reads.
Based in Puerto Rico, operating nationwide.
Interested in clinical partnerships, consulting, and building scalable coverage solutions.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Pain Medicine, 2018 - 2019
University of MichiganResidency, Radiology-Diagnostic, 2014 - 2018
Virginia Commonwealth University Health SystemResidency, Internal Medicine, 2013 - 2014
Virginia Commonwealth University School of MedicineClass of 2013
Certifications & Licensure
AZ State Medical License 2021 - 2027
CO State Medical License 2021 - 2027
PR State Medical License 2021 - 2027
MT State Medical License 2019 - 2027
AR State Medical License 2021 - 2026
WA State Medical License 2021 - 2026
VT State Medical License 2022 - 2026
American Board of Radiology Diagnostic Radiology- American Board of Radiology Pain Medicine
- Join now to see all
Publications & Presentations
PubMed
- 6 citationsPositron Emission Tomography 18F-Fluorodeoxyglucose Uptake Correlates with KRAS and EMT Gene Signatures in Operable Esophageal Adenocarcinoma.Brendan T. Heiden, Nathan T. Patel, Derek J. Nancarrow, Matthew Hermann, Richard K.J. Brown
The Journal of Surgical Research. 2018-08-10 - 15 citations18F-FDG PET intensity correlates with a hypoxic gene signature and other oncogenic abnormalities in operable non-small cell lung cancer.Brendan T. Heiden, Guoan Chen, Matthew Hermann, Richard K.J. Brown, Mark B. Orringer
Plos One. 2018-07-02
External Links
- RightReadMDhttps://rightreadmd.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
